BACE1 and early-onset autosomal dominant Alzheimer disease: This work was performed as part of a project aimed at identifying strong, selective inhibitors of β-secretase (BACE-1) to overcome the shortcomings of the existing drugs to treat Alzheimer’s disease (AD) [38], [39], [40].